Acarix AB (publ) (STO:ACARIX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.284
+0.009 (3.27%)
At close: Feb 27, 2026
23.75%
Market Cap 330.77M
Revenue (ttm) 7.36M
Net Income (ttm) -48.09M
Shares Out 1.16B
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,370,211
Average Volume 1,732,020
Open 0.278
Previous Close 0.275
Day's Range 0.271 - 0.290
52-Week Range 0.191 - 0.471
Beta -0.30
RSI 51.60
Earnings Date Feb 12, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 8
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACARIX
Full Company Profile

Financial Performance

In 2025, Acarix AB's revenue was 7.36 million, an increase of 18.69% compared to the previous year's 6.20 million. Losses were -48.09 million, -27.34% less than in 2024.

Financial Statements

News

There is no news available yet.